The Bioresorbable medical material refers to advanced substances designed to safely break down and be absorbed by the human body after fulfilling their therapeutic purpose. These materials eliminate the need for surgical removal and support natural healing processes.

Bioresorbable Medical Material Market Overview

The Bioresorbable Medical Material Market is witnessing robust expansion, supported by advancements in biomaterials science and the growing demand for minimally invasive surgical solutions. The market size is projected to reach US$ 2.84 billion by 2031 from US$ 1.23 billion in 2022, registering a CAGR of 9.70% during 2023 to 2031. Bioresorbable materials are designed to degrade naturally within the human body after fulfilling their intended function, eliminating the need for secondary surgical removal. Their compatibility with biological systems and ability to support tissue regeneration make them increasingly valuable in modern medical practice.

These materials are extensively used across orthopedics, drug delivery systems, tissue engineering, wound management, and implantable devices. The rising aging population and increasing incidence of orthopedic disorders are major contributors to sustained market growth.

Market Drivers and Growth Factors

One of the primary growth drivers is the increasing global geriatric population. Older individuals are more prone to bone fractures, joint disorders, and degenerative diseases that require surgical intervention. According to data published in the International Journal of Molecular Sciences in March 2022, the global population aged 65 years and above is expected to more than double between 2019 and 2050. This demographic shift significantly increases the demand for advanced surgical materials and implants.

The growing preference for minimally invasive procedures further strengthens the market outlook. Bioresorbable polymers are widely used in molded medical equipment for neurology, orthopedic, and cosmetic surgery. These materials provide mechanical strength, controlled degradation, and physiochemical stability, enabling improved healing and reduced post operative complications.

Technological advancements in polymer chemistry and material engineering are also supporting innovation. Manufacturers are developing high performance polymers with enhanced biocompatibility and tailored degradation profiles to meet specific clinical requirements.

Emerging Opportunities in 3D Printing

The integration of 3D printing technology into bioresorbable material development presents significant growth opportunities. Customized and patient specific implants are becoming more feasible due to advances in additive manufacturing.

In October 2023, Evonik introduced a new line of RESOMER filaments designed for 3D printing high resolution bioresorbable implants. The portfolio includes Poly L lactide co glycolide, Poly L lactide, Polycaprolactone, and Polydioxanone grades. These materials are available in standard and customizable forms, enabling medical device manufacturers to develop personalized implant solutions.

Earlier, in February 2020, the company launched a bioresorbable powder suitable for Selective Laser Sintering 3D printing equipment. Such developments indicate that additive manufacturing will play a crucial role in shaping the next phase of innovation in this market.

Download Sample PDF : https://www.theinsightpartners.com/sample/TIPRE00008231

Segmentation Analysis

The bioresorbable medical material market is segmented based on product type and application.

By product type, the market includes Polylactide, Poly L lactide, Poly DL lactide, Polyglycolide, Polycaprolactone, and others. Polylactide held the largest market share in 2023 due to its widespread application in implants and sutures. However, Poly DL lactide is expected to register the fastest growth during the forecast period because of its enhanced degradation characteristics and improved mechanical properties.

By application, the market is segmented into drug delivery, medical devices, orthopedics, and others. The drug delivery segment accounted for the largest share in 2023. Bioresorbable materials are increasingly used in controlled drug release systems, offering targeted therapy with reduced systemic side effects. Orthopedics also represents a significant segment due to rising fracture cases and sports related injuries.

Regional Insights

Geographically, the market is divided into North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

North America dominates the global market, with the United States holding the largest share, followed by Canada. The region benefits from advanced healthcare infrastructure, high healthcare spending, and strong research and development activities. The increasing adoption of bioresorbable materials in orthopedic implants and surgical devices further accelerates regional growth.

In September 2023, Zeus Industrial Products, Inc. developed Absorv XSE oriented tubing, a customizable bioabsorbable alternative to permanent metallic implants. Such innovations strengthen North America’s leadership position.

Asia Pacific is expected to witness substantial growth due to expanding healthcare infrastructure, rising medical tourism, and increasing awareness about advanced surgical materials.

Competitive Landscape and Key Players

The market is moderately consolidated, with key players focusing on product innovation, mergers, and acquisitions to expand their portfolios.

Notable developments include the acquisition of Tepha Inc. by BD in July 2021, strengthening its resorbable polymer capabilities. In August 2021, Evonik acquired JeNaCell to expand its biomaterials portfolio in medical technology and dermatology. In October 2022, Collagen Matrix, Inc. acquired Polyganics B.V to enhance its bioresorbable device offerings.

Key Players

• Evonik

• Foster Corporation

• Poly Med Corporation

• Ashland

• DSM

• Corbion

• Putnam Plastics

• Zeus Industrial Products, Inc.

Future Outlook

The future of the bioresorbable medical material market appears highly promising, driven by continuous advancements in biomaterials science, personalized medicine, and regenerative healthcare solutions. Increasing integration of 3D printing, nanotechnology, and bioactive compounds into bioresorbable systems is expected to unlock new clinical applications. Growing healthcare investments in emerging economies and expanding research collaborations between academic institutions and manufacturers will further support innovation. As demand for safer, more efficient, and patient friendly treatment solutions rises, bioresorbable materials are likely to become a standard component in next generation medical devices and therapeutic systems.

Other Reports :

Eyelid Surgery Market

Medical Refrigerators Market